These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18311053)

  • 1. [Functional analysis of nuclear receptor FXR controlling metabolism of cholesterol].
    Ohno M
    Yakugaku Zasshi; 2008 Mar; 128(3):343-55. PubMed ID: 18311053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of bile acids and bile acid receptors in metabolic regulation.
    Lefebvre P; Cariou B; Lien F; Kuipers F; Staels B
    Physiol Rev; 2009 Jan; 89(1):147-91. PubMed ID: 19126757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FXR, a multipurpose nuclear receptor.
    Lee FY; Lee H; Hubbert ML; Edwards PA; Zhang Y
    Trends Biochem Sci; 2006 Oct; 31(10):572-80. PubMed ID: 16908160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR: a metabolic regulator and cell protector.
    Wang YD; Chen WD; Moore DD; Huang W
    Cell Res; 2008 Nov; 18(11):1087-95. PubMed ID: 18825165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nuclear receptors FXR and LXRalpha: potential targets for the development of drugs affecting lipid metabolism and neoplastic diseases.
    Niesor EJ; Flach J; Lopes-Antoni I; Perez A; Bentzen CL
    Curr Pharm Des; 2001 Mar; 7(4):231-59. PubMed ID: 11254888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the bile acid receptor FXR].
    Li S; Zhang ZW; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):314-8. PubMed ID: 14992012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear bile acid receptor FXR as pharmacological target: are we there yet?
    Modica S; Moschetta A
    FEBS Lett; 2006 Oct; 580(23):5492-9. PubMed ID: 16904670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.
    Duran-Sandoval D; Cariou B; Fruchart JC; Staels B
    Biochimie; 2005 Jan; 87(1):93-8. PubMed ID: 15733743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LXRS and FXR: the yin and yang of cholesterol and fat metabolism.
    Kalaany NY; Mangelsdorf DJ
    Annu Rev Physiol; 2006; 68():159-91. PubMed ID: 16460270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-dependent coactivation of the human bile acid receptor FXR by the peroxisome proliferator-activated receptor gamma coactivator-1alpha.
    Savkur RS; Thomas JS; Bramlett KS; Gao Y; Michael LF; Burris TP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):170-8. PubMed ID: 15329387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors.
    Redinger RN
    Can J Gastroenterol; 2003 Apr; 17(4):265-71. PubMed ID: 12704471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor signaling in the control of cholesterol homeostasis: have the orphans found a home?
    Ory DS
    Circ Res; 2004 Oct; 95(7):660-70. PubMed ID: 15459087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism.
    Claudel T; Staels B; Kuipers F
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2020-30. PubMed ID: 16037564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
    Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
    Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FXR: a promising target for the metabolic syndrome?
    Cariou B; Staels B
    Trends Pharmacol Sci; 2007 May; 28(5):236-43. PubMed ID: 17412431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FXR signaling in metabolic disease.
    Zhang Y; Edwards PA
    FEBS Lett; 2008 Jan; 582(1):10-8. PubMed ID: 18023284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors.
    Makishima M
    J Pharmacol Sci; 2005 Feb; 97(2):177-83. PubMed ID: 15725701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio.
    Modica S; Bellafante E; Moschetta A
    Front Biosci (Landmark Ed); 2009 Jan; 14(12):4719-45. PubMed ID: 19273385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
    Cariou B
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):685-91. PubMed ID: 19195631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Farnesoid X receptor(FXR)].
    Fujii H
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():309-12. PubMed ID: 11351595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.